As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
|Articles|May 12, 2015
Pharmacy Law MPJE Review Books
Use these review guides to pass the MPJE.
Advertisement
To gain pharmacy licensure, students must pass an examination called the Multistate Pharmacy Jurisprudence Examination (MPJE). The MPJE is a computer-adaptive exam that tests prospective pharmacists on both federal and state-specific pharmacy laws.
The following guide serves as a reference in identifying review books for federal and state pharmacy laws. Always refer to your state’s board of pharmacy website for the most up-to-date laws and regulations. (Note: If your state is not listed, I could not locate any published review books for it.)
Federal pharmacy law:
All state MPJEs:
This is an
extremely
helpful guide to supplement material from review books or directly from the law. $65.
. $130. Breaks down material into 40+ easy to read “QuickCards” for federal law, and 70+ questions and answers for state law. $130.
Arizona
California
. David A Heckman, PharmD. $94.
Connecticut
- Includes federal law review
Florida
. Dr. Anthony J. Cutie. $135.
- Includes federal law review
- Also offers a private, one-to-one review course held in Arsley, New York for an additional fee
Illinois
Indiana
Kentucky
Massachusetts
Michigan
Nebraska
New Jersey
- Includes federal law review
- Also offers a private, one-to-one review course held in Arsley, New York for an additional fee
New York
- Includes federal law review
- Also offers an in-person course review for an additional fee at Long Island University
- Also offers a private, one-to-one review course held in Arsley, New York for an additional fee
North Carolina
Ohio
Pennsylvania
David A Heckman, PharmD
. $84.
- Also offers a private, one-to-one review course held in Arsley, New York for an additional fee
Tennessee
Texas
Virginia
Washington
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
3
Could CAR T Therapy Become Adjustable After Infusion?
4
Using CKDintercept to Build Interdisciplinary Kidney Care
5